SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001437749-20-007630
Filing Date
2020-04-13
Accepted
2020-04-13 18:21:03
Documents
1
Period of Report
2020-04-09

Document Format Files

Seq Description Document Type Size
1 FORM 4 rdgdoc.html 4  
1 FORM 4 rdgdoc.xml 4 6162
  Complete submission text file 0001437749-20-007630.txt   7587
Mailing Address 107 SPRING STREET SEATTLE WA 98104
Business Address 107 SPRING STREET SEATTLE WA 98104 206.588.0256
ATOSSA THERAPEUTICS, INC. (Issuer) CIK: 0001488039 (see all company filings)

IRS No.: 264753208 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ATOSSA GENETICS INC. 1616 EASTLAKE AVE. E SUITE 510 SEATTLE WA 98102
Business Address
Guse Kyle (Reporting) CIK: 0001566618 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35610 | Film No.: 20789580